![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan (S.K., K.N., Y.T., C.T., K.S., S.O.); PhoenixBio Co., Ltd., Higashihiroshima, Japan (T.I., T.H.); and Nihon Pharmaceutical University, Inamachi, Saitama, Japan (S.K.)
Aldehyde oxidase-mediated oxidation of N1-methylnicotinamide to N1-methyl-2-pyridine-5-carboxamide (2-PY) and N1-methyl-4-pyridone-5-carboxamide (4-PY) in chimeric mice constructed by transplanting human hepatocytes into urokinase-type plasminogen activator-transgenic severe combined immunodeficient mice was examined in vivo and in vitro. The activity in liver cytosol of chimeric mice with a high replacement index was approximately 4-fold higher than that in control mice. Furthermore, the oxidation products in control mice were 2-PY and 4-PY, whereas, in chimeric mice, the major product was 2-PY, as in humans. The aldehyde oxidase in chimeric mouse liver was confirmed to be of human type by immunoblotting analysis. The ratio of pyridones (2-PY/4-PY) excreted in the urine of chimeric mice was closer to that of humans than to that of control mice. Thus, the aldehyde oxidase in chimeric mice has human-type functional characteristics.
This article has been cited by other articles:
![]() |
T. Inoue, K. Nitta, K. Sugihara, T. Horie, S. Kitamura, and S. Ohta CYP2C9-Catalyzed Metabolism of S-Warfarin to 7-Hydroxywarfarin in Vivo and in Vitro in Chimeric Mice with Humanized Liver Drug Metab. Dispos., December 1, 2008; 36(12): 2429 - 2433. [Abstract] [Full Text] [PDF] |
||||